Disc Sees Promise In Hematology With Former Roche Schizophrenia Candidate

 
• By Joseph Haas
  
Sun sensitive
Disc's bitopertin shows ability to improve sunlight tolerance in Phase II trial • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D